

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company applying its proprietary. Among its major competitors, Pieris Pharmaceuticals is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $74.23M